# TopTaiwan

> TopTaiwan is a VC fund backing Biotechnology, Medical and Pharmaceutical. See 22 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 22
- Last investment: Mar 2025
- Lead investor: 5%
- Last updated: Aug 2026
- Website: http://www.toptaiwan.com.tw

TopTaiwan is a VC fund focused on Biotechnology and Medical. TopTaiwan operates as a venture capital management firm. It seeks to invest in industries such as technology, biotechnology, renewable energy, consumer retail, food and beverages, healthcare, and auto parts. The firm was founded in 1996 and is headquartered in Taipei City, Taiwan.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1M–$3.1M |
| Series A | $3.7M–$6.3M |
| Series B | $10M–$49M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 7 | 32% |
| Medical | 6 | 27% |
| Pharmaceutical | 5 | 23% |
| Artificial Intelligence | 5 | 23% |
| Health Care | 4 | 18% |

44 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 10 | 45% |
| Series B | 6 | 27% |
| Series A | 3 | 14% |
| Venture - Series Unknown | 2 | 9% |
| Series D | 1 | 5% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Taiwan | 14 | 64% |
| United States | 4 | 18% |
| Japan | 1 | 5% |
| Singapore | 1 | 5% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| GRAID Technology | GRAID Technology is headquartered in Silicon Valley, California with an R&D center in Taipei, Taiwan, and has been formed by a team that has more than 15 years’ experience in the SDS, ASIC and storage industries. Our extraordinary software & hardware solution has redefined every aspect of an SSD RAID card, and makes GRAID SupremeRAID™ themost powerful and flexible NVMe SSD RAID card in the world. | $30M | Series B | Mar 04, 2025 |  |
| MedicalTek | MedicalTek Co., Ltd. (MDTK) strives to excellence in ingenuity and quality and is committed to continue delivering reliable and user friendly solutions to the health and medical industries. The company keep on focusing on the unmet needs that exist in the Minimally Invasive Surgery, to develop and manufacture the products that can be closer to theneeds of surgeons. | $3.7M | Series A | Dec 30, 2024 |  |
| PopChill | PopChill generates an online marketplace for second-hand trade, enabling users to share their fashion styles and sell idle items. | $3.1M | Seed | May 21, 2024 |  |
| Moldintel | Moldintel is a smart solution provider focusing on the plastic injection molding industry, like a virtual machine adjuster, assisting factories to increase production capacity and stabilize yield, and further create a completely unmanned adaptive production process through factory machine networking. | $2M | Seed | May 01, 2024 |  |
| Kneron | Kneron specializes in designing and developing integrated software and hardware solutions that enable artificial intelligence to function on devices at the edge. Their products serve a variety of applications, including smart homes, smart surveillance, smartphones, robots, drones, and IoT devices. Kneron offers AI System-on-Chips, visualrecognition software development kits, and intellectual property for neural processing units. | $49M | Series B | Sep 26, 2023 |  |
| AnnJi Pharmaceutical | AnnJi Pharmaceutical is a clinical-stage drug development company that specializes in developing small molecules that address unmet medical needs in the areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy’s disease, and SBMA (Spinal and bulbar muscular atrophy). Thefocus of the company is on creating global collaborations and business partnerships in the late-stage product development and commercialization of pharmaceutical drugs. | $21.1M | Venture - Series Unknown | Jul 05, 2023 |  |
| PressPlay | PressPlay focuses on sharing entertainment and knowledge on new generation-centered web. Our team is dedicated to creating both original and valuable content, employing the foremost creative minds in development, production, post-production, and quality improvement. PressPlay handles not merely management, operations for content of next generation,but also development for the most promising young stars. We won’t give up until reach the end to build the best content community for generation Z. |  | Series B | Oct 13, 2022 |  |
| Hahow | Hahow is an educational marketplace that allows experts to share their knowledge and earn money through crowdfunded video course.At Hahow, talent and knowledge are not only valued but also valuated. More importantly, Hahow allows for such skills to be more effectively passed on by lowering the barriers for cross-domain learning.We believe thateducation is a way of life. Through proper utilization of technology and creativity, we hope to serve as the catalyst for the transfer and circulation of knowledge and skills, thereby spreading the joy of learning worldwide. | $10M | Series B | Apr 06, 2022 |  |
| ARCE Therapeutic | ARCE Therapeutics is a biotech company, specializes in developing proprietary gene-modified cellular immunotherapies. |  | Seed | Jan 01, 2022 |  |
| Obigen pharma | Obigen Pharma is a biopharmaceutical company focused on developing and manufacturing botulinum toxin products. |  | Seed | Jan 01, 2022 |  |

10 of 22 investments shown.

## Co-investors
- [National Development Fund of Taiwan Government](https://shizune.co/investors/profile/national-development-fund-of-taiwan-government) — VC Fund, 4 deals together
- [500 Global](https://shizune.co/investors/profile/500-startups) — VC Fund, 3 deals together
- [Darwin Venture Management](https://shizune.co/investors/profile/darwin-venture-management) — VC Fund, 3 deals together
- [CDIB Capital](https://shizune.co/investors/profile/cdib-capital) — VC Fund, 2 deals together
- [Delta Electronics Capital](https://shizune.co/investors/profile/delta-electronics-capital) — VC Fund, 2 deals together
- [Foxconn Co-GP Fund](https://shizune.co/investors/profile/foxconn-co-gp-fund) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [AME Cloud Ventures](https://shizune.co/investors/profile/ame-cloud-ventures) — VC Fund
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [National Development Fund of Taiwan Government](https://shizune.co/investors/profile/national-development-fund-of-taiwan-government) — VC Fund
- [Darwin Venture Management](https://shizune.co/investors/profile/darwin-venture-management) — VC Fund
- [AVA Angels](https://shizune.co/investors/profile/ava-angels) — VC Fund

## Featured in investor lists
- [All Investors in Taiwan](https://shizune.co/investors/investors-taiwan)
- [All VC Funds in Taiwan](https://shizune.co/investors/vc-funds-taiwan)
- [Health Care VC Funds in Taiwan](https://shizune.co/investors/health-care-vc-funds-taiwan)
- [Medical Investors in Taiwan](https://shizune.co/investors/medical-investors-taiwan)
- [Medical VC Funds in Taiwan](https://shizune.co/investors/medical-vc-funds-taiwan)
- [Artificial intelligence VC Funds in Taiwan](https://shizune.co/investors/artificial-intelligence-vc-funds-taiwan)

## FAQ

### What does TopTaiwan invest in?

TopTaiwan invests primarily in Biotechnology, Medical and Pharmaceutical startups, most often at Seed and Series B stage. Most of the 22 investments tracked by Shizune back companies in Taiwan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is TopTaiwan's check size?

TopTaiwan typically joins rounds of $1M–$3.1M at Seed, $3.7M–$6.3M at Series A and $10M–$49M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds TopTaiwan participates in.

### When did TopTaiwan last invest?

The most recent investment recorded for TopTaiwan closed in Mar 2025. Shizune tracks 22 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co